Provincial report card

Alberta

3 of 8 categories assessed · Evidence assessed to August 2025

Not gradedInsufficient data

Only 3 of 8 categories could be assessed from the research inventories, below the five-category minimum for a grade. The mean of the assessed categories (2.7) is shown for transparency only. Missing evidence is never scored as zero.

How Alberta scored, category by category

1 · Strategy & pancreatic focus

2 / 4

Alberta's Cancer Strategic Clinical Network Plan 2024–2027 and "Changing Our Future: Alberta's Cancer Plan to 2030" set three strategic directions (collaboration, data-driven improvement, stakeholder engagement), delivered through CancerControl Alberta; no pancreatic-specific provisions are documented.

2 · Biomarker & genetic testing

3 / 4

Alberta Precision Laboratories' Cancer Genomics Program provides NGS-based testing covering BRCA, MSI, and other PDAC-related markers, recorded "Operational".

3 · Drug coverage & patient costs

3 / 4

Alberta carries the corpus's measured low private-pay share: 12% of take-home oncology medicine spending privately paid, vs up to 59% in the Atlantic groupings — i.e., 88% public funding (PMPRB 2021, 2019 data). This score rests on that measured share; the corpus does not document Alberta's exceptional-access processing timelines.

4 · Clinical trials access

Not assessable

Not obtainable: Alberta is listed among the provinces with clinical trial sites, but no Alberta enrolment rate, site-level detail, or pancreatic-trial evidence is in the corpus to place a band.

5 · Timely care — waits & surgical capacity

Not assessable

Not obtainable: Alberta wait times and pancreatic surgical capacity are not covered in the corpus.

6 · Travel & transport support

Not assessable

Not obtainable: Alberta travel and transport supports are not covered in the corpus.

7 · Workforce, navigation & support

Not assessable

Not obtainable: Alberta workforce and navigation are not covered in the corpus.

8 · Research funding & representation

Not assessable

Not obtainable: Alberta's institution-level CIHR register presence is not published in the findings. Alberta's Tomorrow Project (cohort ~55,000, established 2000) is documented research infrastructure but is not pancreatic research funding.

Strongest areas

Biomarker & genetic testing3 of 4
Drug coverage & patient costs3 of 4

Grades rest on structured research inventories reviewed and verified by The Heather Cutler Foundation. They assess documented systems, not individual care. See all thirteen jurisdictions · Read the full report